Related Experiment Videos

[Geriatric medicine. Current status and perspectives for the future]

G F Kolb1

  • 1Abteilung für Innere Medizin, Fachbereich Geriatrie, St. Bonifatius Hospital, Wilhelmstr. 13, 49808, Lingen (Ems), Deutschland. gerald.kolb@bonifatius-lingen.de

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|November 28, 2012
PubMed

Insights

Geriatric medicine faces challenges from increasing comorbidities in aging populations. Dementia care requires specialized resources, highlighting a critical need for enhanced training in elder care.

Area of Science:

  • Geriatric Medicine
  • Demographic Health Trends
  • Epidemiology of Aging

Context:

  • Western societies are experiencing rapid demographic shifts with aging populations.
  • Increased incidence and severity of comorbidities are primary concerns in the elderly.
  • Three main epidemiological classes of comorbidities are identified: cardiovascular diseases, malignancies, and cognitive impairments (dementia).

Purpose:

  • To outline the distinct challenges posed by different comorbidity types in geriatric medicine.
  • To highlight the varying effectiveness of current strategies for managing age-related diseases.
  • To emphasize the critical need for specialized human resources and training in elder care, particularly for dementia.

Summary:

  • Geriatric medicine is a growing field due to aging populations and rising comorbidity rates.
  • While cardiovascular diseases and malignancies have seen therapeutic advances, dementia lacks effective preventive or therapeutic measures.
  • The growing need for specialized elder care professionals, especially for dementia, presents a significant societal challenge.

Impact:

  • Informs strategies for managing diverse comorbidities in the elderly.
  • Underscores the urgent need for investment in dementia research and care infrastructure.
  • Highlights the societal imperative to train more healthcare professionals specializing in geriatric medicine and elder support.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...